Hardman & Co Issues Research Report

Hardman & Co issues research report on Real Good Food plc (RGD.L)

Profits to rise 30% FY17

We reinstate FY17 RGF estimates, having suspended forecasts in February post the Real Good Food trading update on 1st of that month. Food manufacturing is a robust sector - as long as the producer can manage or minimise exposure to the commodity-based multiple grocery lines. A number of quoted producers have benefitted from trends, for example such as consolidation (Finsbury Foods), pork consumption (Cranswick). Real Good Food's (RGF) underlying trends have diversity, and one main thrust is the continued rise in baking as a hobby. This offers value-add consumer demand. The road has some bumps but is fruitful.

Please click here for the full report:

http://www.hardmanandco.com/docs/default-source/company-docs/real-good-food-company-documents/04-04-16-profits-to-risefy17

www.hardmanandco.com

About Hardman & Co: For the past 20 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.